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Ubiquitin-specific protease 14 (USP14) is a major deubiquitinating enzyme and a key
determinant of neuromuscular junction (NMJ) structure and function. We have previously
reported dramatic ubiquitin depletion in the nervous systems of the USP14-deficient
ataxia (axJ) mice and demonstrated that transgenic ubiquitin overexpression partially
rescues the axJ neuromuscular phenotype. However, later work has shown that ubiquitin
overexpression does not correct the axJ deficits in hippocampal short term plasticity, and
that transgenic expression of a catalytically inactive form of USP14 in the nervous system
mimics the neuromuscular phenotype observed in the axJ mice, but causes a only a
modest reduction of free ubiquitin. Instead, increased ubiquitin conjugates and aberrant
activation of pJNK are observed in the nervous systems of the USP14 catalytic mutant
mice. In this report, we demonstrate that restoring free ubiquitin levels in the USP14
catalytic mutant mice improved NMJ structure and reduced pJNK accumulation in
motor neuron terminals, but had a negative impact on measures of NMJ function, such
as motor performance and muscle development. Transgenic expression of ubiquitin
had a dose-dependent effect on NMJ function in wild type mice: moderate levels
of overexpression improved NMJ function while more robust ubiquitin overexpression
reduced muscle development and motor coordination. Combined, these results suggest
that maintenance of free ubiquitin levels by USP14 contributes to NMJ structure, but that
USP14 regulates NMJ function through a separate pathway.
Keywords: neuromuscular junction, ubiquitin, USP14, pJNK, proteasomes, motor neuron and deubiquitinating
enzyme
Abbreviations: TgCA (transgene expressing catalytically inactive USP14, generated by mutating the active site cysteine to an
alanine residue, expressed under the neuronal Thy1.2 promoter; also refers to mice expressing this transgene); TgUb (trans-
gene expressing ubiquitin under the Thy1.2 promoter; also refers to mice expressing this transgene); TgUb-H (a transgenic
founder line with more robust ubiquitin overexpression than TgUb); TgCA,TgUb (mice expressing both TgCA and TgUb).
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Introduction
Ubiquitination can regulate a diverse array of cellular path-
ways depending on the number of ubiquitin monomers con-
jugated onto a protein and the internal lysine residue used to
form the ubiquitin chain. These pathways regulate protein sta-
bility (Hershko and Ciechanover, 1998), activity (Schmukle and
Walczak, 2012; Humphrey et al., 2013; Zhou et al., 2013), and
localization (Tanno and Komada, 2013). The accumulation of
ubiquitin-positive aggregates is a hallmark of neurodegenerative
diseases (Perry et al., 1987; Lowe et al., 1988; Jara et al., 2013),
suggesting that sequestration of ubiquitin, and the consequent
reduction of ubiquitin availability, could contribute to neuronal
dysfunction. This suggestion is supported by the hypothalamic
dysfunction and neurodegeneration observed in mice lacking the
ubiquitin gene Ubb (Ryu et al., 2008).
Although ubiquitin is encoded by four genes in the mam-
malian genome (Lund et al., 1985; Wiborg et al., 1985; Baker and
Board, 1987, 1991; Finley et al., 1989; Redman and Rechsteiner,
1989), the equilibrium between ubiquitin conjugated onto pro-
teins and free ubiquitin is largely controlled by the oppos-
ing actions of ubiquitin ligases and deubiquitinating enzymes
(DUBs; Hallengren et al., 2013). We have previously shown
that loss of the proteasome-associated DUB ubiquitin-speciﬁc
protease 14 (USP14) in the ataxia (axJ ) mice results in peri-
natal lethality, reduced muscle development, and structural and
functional defects at the neuromuscular junction (NMJ). Loss
of USP14 also severely alters ubiquitin homeostasis by causing
a dramatic depletion of free ubiquitin in the brain and spinal
cord (Anderson et al., 2005; Chen et al., 2009). Ubiquitin lev-
els were most severely aﬀected at the synapse, suggesting that
the NMJ deﬁcits in the axJ mice are due to ubiquitin deple-
tion (Chen et al., 2009). In fact, neuronal-speciﬁc transgenic
expression of ubiquitin corrects the reduced muscle develop-
ment, altered NMJ structure, reduced synaptic transmission, and
perinatal lethality observed in the axJ mice (Chen et al., 2011).
Although these ﬁndings suggest a role for USP14’s in the main-
tenance of free ubiquitin pools in the nervous system, later work
showed ubiquitin complementation does not rescue the deﬁcits
in hippocampal short-term plasticity observed in the axJ mice
(Walters et al., 2014).
Furthermore, we recently reported that transgenic expression
of a dominant-negative, catalytically inactive USP14 species in
the murine nervous system recreates many of the essential phe-
notypes observed in the axJ mice, including deﬁcits in NMJ
structure, poor motor performance, and reduced muscle devel-
opment (Vaden et al., 2015). In contrast to the axJ mice, however,
the USP14 catalytic mutant mice have a normal lifespan and
only a modest decrease in free ubiquitin. Instead, the spinal
cords of the USP14 catalytic mutant mice show an increase in
levels of ubiquitin conjugates linked through lysine 63 (K63),
which are known to promote kinase activation (Yang et al.,
2010; Humphrey et al., 2013). Consistent with this ﬁnding, the
USP14 catalytic mutant mice have increased activation of the
ubiquitin-dependent mixed lineage kinase 3 (MLK3) pathway,
which signals through c-Jun N-terminal kinase (JNK; Vaden
et al., 2015). As expected from the well-documented role of pJNK
in rearranging synaptic architecture in invertebrates (Etter et al.,
2005; Collins et al., 2006; Drerup and Nechiporuk, 2013), in vivo
inhibition of JNK signiﬁcantly improvedNMJ structure andmus-
cle development in the USP14 catalytic mutant mice (Vaden et al.,
2015).
These ﬁndings led us to hypothesize that, in addition to
maintaining ubiquitin homeostasis, USP14’s catalytic activity is
required for the termination of ubiquitin signaling cascades and,
consequently, that the increase in ubiquitin conjugates observed
in the spinal cords of the USP14 catalytic mutant mice can
alter neuronal function independent of the reduction of free
ubiquitin. To directly test this hypothesis, we generated mice
expressing both catalytically inactive USP14 (TgCA) and ubiq-
uitin (TgUb) under the neuronal Thy1.2 promoter. The spinal
cords of the resulting TgCA, TgUb mice had control levels of
free ubiquitin and a nearly twofold increase in ubiquitin con-
jugates. The motor performance and muscle development of
the double transgenic TgCA,TgUb mice were reduced com-
pared to both TgCA mice and controls, underlining the need
for USP14-dependent deubiquitination events in the nervous
system. However, despite the detrimental eﬀects of ubiquitin
complementation on the overall phenotype of the TgCAmice, the
structure of the NMJ was improved, and the amount of pJNK-
positive pathology was decreased, in the TgCA,TgUb mice com-
pared to TgCAmice. Additionally, we found that overexpression
of ubiquitin had a bidirectional, dose-dependent eﬀect on mus-
cle mass, motor function, and measures of synaptic transmission
even in wild type mice where USP14’s activity was intact. These
data suggest that ubiquitin complementation in axJ mice indi-
rectly corrects the functional deﬁcits caused by loss of USP14 and
demonstrate that increased protein ubiquitination alters motor
function.
Materials and Methods
Animals
Wild type C57BL/6J, Thy1-YFP mice (16JRS, Jackson
Laboratories, Bar Harbor, ME, USA), transgenic mice expressing
USP14 (TgUsp14) catalytically inactive USP14 (TgCA; previously
referred to as TgUsp14CA), ubiquitin (TgUb), or both catalyt-
ically inactive USP14 and ubiquitin (TgCA,TgUb) have been
maintained in our breeding colony at the University of Alabama
at Birmingham, which is fully accredited by the Association
for Assessment and Accreditation of Laboratory Animal Care
International. We have previously described the generation of
the TgUsp14 (Crimmins et al., 2006), and TgUb (Chen et al.,
2011), and TgCA mice (Vaden et al., 2015), and all transgenes
are expressed from the neuronal Thy1.2 promoter. Generation of
TgUb mice resulted in two diﬀerent founder lines with diﬀering
ubiquitin expression, TgUb-H (high expresser) and TgUb (low
expresser). Double transgenic (TgCA,TgUb) mice were generated
by breeding male TgCA mice to female TgUb mice. All mouse
lines were maintained on a C57BL/6J background and transgenic
mice were heterozygous for the transgene(s) of interest. Research
was conducted without bias toward the sex of animals used
for each study, and equal numbers of male and female mice
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were used. All research complied with the United States Animal
Welfare Act and other federal statutes and regulations relating
to animals and experiments involving animals, and adhered to
principles stated in the Guide for the Care and Use of Laboratory
Animals, United States National Research Council. In addition,
all experiments were carried out with the approval of the
University of Alabama at Birmingham’s Institutional Animal
Care and Use Committee.
Isolation of Proteins
Mice were deeply anesthetized with isoﬂurane prior to rapid
decapitation. Spinal cords were removed and homogenized in
modiﬁed RIPA buﬀer containing 50 mM Tris, pH 7.5, 150 mM
NaCl, 5 mM MgCl2, 0.5 mM EGTA, 1 mM EDTA, 0.5% SDS,
1% Triton X-100, and 1% sodium deoxycholate. Complete pro-
tease inhibitor (Roche, Indianapolis, IN, USA), phosphatase
inhibitor cocktail III (Sigma Aldrich, St. Louis, MO, USA), and
50 μM PR-619 (inhibitor of DUBs, Life Sensors, Malvern, PA,
USA) were added to the homogenization buﬀer per manu-
facturer instructions. Following homogenization, samples were
sonicated and centrifuged at 17,000 × g for 10 min at 4◦C.
The supernatants were removed and stored immediately at
−80◦C. Protein concentrations were determined using the bicin-
choninic acid (BCA) protein assay kit from Pierce (Rockford,
IL, USA).
Immunoblotting and Quantitation
Proteins were resolved on 10% Tris-glycine gels and transferred
onto nitrocellulose membranes. BSA (2%) in PBS containing
0.1% NP-40 was used to block the membranes and dilute the pri-
mary and secondary antibodies. HRP-conjugated secondary anti-
bodies (Southern Biotechnology Associates, Birmingham, AL,
USA) and SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientiﬁc, Rockford, IL, USA) were used for detec-
tion. For detection of ubiquitin, proteins were resolved on
4–12% NuPage Tris-bis gels (Life Technologies, Grand Island,
NY, USA) and transferred onto PVDF membranes. Membranes
were treated with 0.1% glutaraldehyde in PBS for 20 min prior
to blocking in PBS containing 2% BSA and 0.1% NP-40. The
secondary antibody was diluted into PBS containing 1% non-
fat dry milk and 0.1% NP-40. For quantitation, all blots were
scanned using a Hewlett-Packard Scanjet 3970, and band density
was quantiﬁed with UN-SCAN-IT gel digitizing software (Silk
Scientiﬁc, Inc., Orem, UT, USA).
Antibodies
The following antibodies were used: USP14 (Anderson et al.,
2005), β-tubulin (Developmental Studies Hybridoma Bank,
Iowa City, IA, USA); Ubiquitin (UAB Hybridoma Facility,
Birmingham, AL, USA); pJNK, and JNK (Cell Signaling
Technology, Danvers, MA, USA).
Open Field
Animals were handled 1 day prior to open ﬁeld testing.
Locomotor activity was measured in an open ﬁeld chamber
(43.2 cm × 43.2 cm × 30.5 cm) for 15 min by an automated
video tracking system (Med Associated, St. Albans, VT, USA).
The ﬁrst 5 min were not analyzed to account for habituation to
the chamber.
Rotarod
Motor coordination was tested by placing mice on a rotating
rod (ENV-575, Med Associates), which accelerated from 3.5 to
35 rpm over a 5-min period. Latency to fall was recorded over
three trials, each separated by 1 h, and the individual trials for
each animal were averaged.
Quantitative PCR
Total RNA was isolated from gastrocnemius muscles or spinal
cords using RNA-STAT60 (Tel-Test, Friendswood, TX, USA)
and reverse transcribed using the Superscript VILO cDNA syn-
thesis kit (Life Technologies) per manufacturer instructions.
Individual gene assays were purchased from Applied Biosystems
for each of the RNAs analyzed: AChR-α (Mm00431629_m1),
AChR-ε (Mm00437411_m1), and AChR-γ (Mm00437419_m1).
Ct values were generated using Gapdh (Mm99999915_g1) as
an internal standard. All values are reported as mean ± SEM of
at least three diﬀerent animals per genotype, run in triplicate.
NMJ immunostaining and confocal imaging
Whole mount immunostaining of the tibialis anterior (TA) mus-
cle was performed as described (Vaden et al., 2015). Brieﬂy, the
TA muscle was immersed in ice-cold PBS containing 2% PFA
for 1 h following dissection and immediately teased into thin
bundles. Muscle bundles were then transferred to PBS contain-
ing 1% PFA and 1% Triton (PBS-T) and incubated overnight at
4◦C with constant rocking. To improve visualization of axons
and ultra-terminal sprouting, all mice used for NMJ immunos-
taining carried the Thy1-YFP transgene in addition to the trans-
gene(s) of interest. Endplates were labeled by a 1 h room tem-
perature incubation with rhodamine-conjugated α-bungarotoxin
(α-BTX) and prepared for antibody application by a 1 h incuba-
tion in a blocking buﬀer containing 2% bovine serum albumin
and 4% normal goat serum in PBS-T. For pJNK immunos-
taining, muscle bundles were incubated with primary antibody
(pJNK, ##81E11, Cell Signaling Technology) for 5 days at 4◦C
with constant rocking. All images were captured using a Zeiss
LSM 510 Meta confocal microscope (Carl Zeiss, Oberkochen,
Germany). Endplate size was determined by tracing the circum-
ference of the α-BTX-positive post-synaptic AChR cluster and
computing area using ImageJ software (NIH, Bethesda, MD,
USA).
Statistical Analysis
All analyses were carried out using GraphPad Prism version for
6.0 for Mac OS X (GraphPad Software, La Jolla, CA, USA). For
scaled variables, signiﬁcant diﬀerences among genotypes were
determined with a one-way ANOVA after assumptions for nor-
mality were veriﬁed with a D’Agostino and Pearson omnibus
normality test with alpha set to 0.05. Post hoc comparisons
were made with independent samples t-tests with Bonferroni-
corrected alpha. In samples in which one or more genotype did
not meet the assumption of normality, signiﬁcant diﬀerences
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were determined with a Kruskal–Wallis test and post hoc com-
parisons were made with Mann–Whitney tests with Bonferroni-
corrected alpha.
Results
Loss of USP14’s DUB Activity Increases
Ubiquitin Conjugates
To assess the interaction of USP14 with cellular ubiquitin pools,
we performed immunoblot analysis on spinal cord extracts from
wild type, TgCA, and axJ mice (Figure 1A). TgUsp14mice, which
overexpress wild type USP14 in the nervous system (Crimmins
et al., 2006), were included as a control. As previously reported
(Anderson et al., 2005; Chen et al., 2009), loss of USP14 in the
axJ mice resulted in signiﬁcant decreases in free ubiquitin lev-
els, whereas neuronal expression of catalytically inactive USP14
in the TgCA mice led to only a modest reduction in free ubiq-
uitin levels (Figures 1A,C). Instead, loss of USP14’s catalytic
activity led to the retention of more proteins in a ubiquiti-
nated state, as indicated by the increase in ubiquitin conjugates
observed in the spinal cords of TgCAmice compared to controls
(Figures 1A,B). We also observed both an increase in free ubiq-
uitin and a reduction in ubiquitin conjugates in the spinal cords
of the mice overexpressing wild type USP14 (TgUsp14), suggest-
ing that USP14’s DUB activity makes a signiﬁcant contribution to
protein deubiquitination.
Neuronal-Specific Over-Expression of
Ubiquitin is Detrimental to TgCA Mice
To test the hypothesis that increased ubiquitin conjugates, and
not depletion of free ubiquitin, cause the motor neuron dysfunc-
tion in TgCAmice, we restored free ubiquitin levels in the TgCA
mice by generating double transgenic mice expressing both TgUb
and TgCA under the neuronal Thy1.2 promoter. The resulting
TgCA,TgUb mice expressed wild type levels of free ubiquitin
as well as an increase in ubiquitin conjugates above what was
observed in the TgCA mice (Figures 2A–C). Consistent with
our previous report (Vaden et al., 2015), there was no diﬀer-
ence in body mass between 4-weeks-old TgCAmice and controls
(Figure 2D), but there was a signiﬁcant reduction in the mass
of the gastrocnemius muscles in the TgCA mice compared to
controls (Figure 2E). While transgenic expression of ubiqui-
tin increased body and muscle mass in the axJ mice (Chen
et al., 2011), both parameters were signiﬁcantly reduced in the
TgCA,TgUb mice compared to both control and TgCA mice
(Figures 2D,E). Furthermore, whereas rotarod performance in
axJTgUb mice is improved over axJ mice (Chen et al., 2011),
the TgCA,TgUb mice did not perform better than TgCA mice in
this assay (Figure 2F). In fact, when we measured motor func-
tion in the less demanding open ﬁeld assay, the TgCA,TgUbmice
showed reduced ambulatory distance (Figure 2G) and velocity
(Figure 2H) compared to both wild type and TgCA mice. In
contrast, ubiquitin overexpression alone, in TgUb mice, caused
increased body and gastrocnemius mass (Figures 2D,E) and
ambulatory distance in the open ﬁeld assay (Figure 2G) com-
pared to controls.
FIGURE 1 | Effects of manipulating USP14 expression on neuronal
ubiquitin pools. (A) Representative immunoblot of spinal cord lysates taken
from 4-weeks-old wild type, TgCA, TgUsp14, and axJ mice, probed for
ubiquitin. β-tubulin was used as a loading control. (B) Quantitation of the
levels of ubiquitin conjugates, normalized to wild type levels; [F (3,30) = 20.35,
p < 0.0001, one-way ANOVA]. (C) Quantitation of the levels of free ubiquitin,
normalized to wild type levels; [F (3,30) = 59.15, p < 0.0001, one-way
ANOVA]. Symbols represent unpaired t-tests compared against wild type and
corrected for multiple comparisons with a Bonferroni adjustment, where
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. n = at least three animals per genotype,
run in duplicate.
We have previously shown that deﬁcits in motor func-
tion and NMJ synaptic transmission are inversely related to
muscle AChR transcript levels, and, in particular, that expres-
sion of the fetal AChR-γ subunit is dramatically increased
in adult animals with motor and synaptic deﬁcits (Chen
et al., 2009, 2011; Vaden et al., 2015). As predicted by
their poor open ﬁeld performance, AChR-α, -ε, and -γ tran-
scripts were signiﬁcantly increased in TgCA,TgUb mice over
all other genotypes, including TgCA (Figures 3A–C). Finally,
there was a signiﬁcant decrease in AChR-γ transcripts in
TgUb mice compared to controls (Figure 3C), and a trend
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FIGURE 2 | Ubiquitin complementation does not rescue body mass,
muscle mass, or motor deficits in TgCA mice. (A) Representative
immunoblots of ubiquitin and USP14 from spinal cords of 4-weeks-old wild
type; TgCA, TgCA, TgUb, and TgUb mice. β-tubulin was used as a loading
control. (B) Quantitation of the levels of ubiquitin conjugates, normalized
to wild type levels; [F (3,28) = 17.36, p < 0.0001, one-way ANOVA].
(C) Quantitation of the levels of free ubiquitin, normalized to wild type levels;
[F (3,12) = 11.70, p < 0.001, one-way ANOVA]. (D) Body mass
[F (3,56) = 9.03, p < 0.0001, one-way ANOVA] and (E) gastrocnemius
muscle mass [F (3,70) = 94.72, p < 0.0001, one-way ANOVA] of
4-weeks-old mice. n = at least 12 animals per genotype. (F) Latency to fall
from beam during a rotarod assay [F (3,26) = 38.36; p < 0.0001, one-way
ANOVA]. (G) Total ambulatory distance [F (3,29) = 9.26; p < 0.001, one-way
ANOVA] and (H) velocity [F (3,26) = 6.56; p < 0.01, one-way ANOVA] during
10 min open field assay. For (F–H), n = at least five animals per genotype.
All data are shown as mean ± SEM. Symbols represent unpaired t-tests
compared against wild type and corrected for multiple comparisons with a
Bonferroni adjustment, where ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. In
(B,C), an additional unpaired t-test with Bonferroni adjustment was used to
compare TgCA and TgCA,TgUb mice.
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FIGURE 3 | Consequences of ubiquitin overexpression on AChR
transcript levels in TgCA mice. qPCR analysis of AChR (A) –α
[F (3,22) = 133.1; p < 0.0001, one-way ANOVA], (B) –ε [F (3,28) = 30.03;
p < 0.0001, one-way ANOVA], and (C) –γ [F (3,19) = 35.56; p < 0.0001,
one-way ANOVA] subunit mRNA abundance in 4-weeks-old wild type; TgCA;
TgCA,TgUb, and TgUb mice expressed as relative fold change from wild type.
n = at least four animals per genotype, run in triplicate. Data are shown as
mean ± SEM. Symbols represent unpaired t-tests corrected for multiple
comparisons with a Bonferroni adjustment where ∗p < 0.05, ∗∗∗p < 0.001.
toward decreased AChR-α and -ε transcripts (Figures 3A,B).
Together with our previous report, these data demonstrate
that increased ubiquitin expression in the presence of catalyt-
ically inactive USP14 (in the TgCA,TgUb mice) has drasti-
cally diﬀerent eﬀects than when USP14 is absent (axJTgUb
mice).
Ubiquitin has a Dose-Dependent Effect on
Motor Function in Wild Type Mice
Loss of USP14’s catalytic activity leads to a greater increase in
ubiquitin conjugates in TgCA,TgUb spinal cords than ubiqui-
tin overexpression alone causes in the spinal cords of TgUb
mice (Figure 2). To determine whether increased protein ubiq-
uitination in the nervous system could alter neuromuscular
function independently of reduced USP14 activity, we com-
pared muscle mass, AChR expression, and rotarod perfor-
mance in the TgUb mice used in previous experiments with
another transgenic founder line (TgUb-H) that has higher lev-
els of ubiquitin expression (Figures 4A–C). The gastrocne-
mius muscles of 4- to 6-weeks-old female TgUb mice were
signiﬁcantly larger than those of controls (Figure 4D). In
contrast, the increased ubiquitin expression in the TgUb-H
mice resulted in signiﬁcantly decreased gastrocnemius mass
compared to controls (Figure 4D). The same was true
for male wild type, TgUb, and TgUb-H mice (data not
shown). Further, we found that TgUb-H mice had a signif-
icant increase in the abundance of fetal AChR-γ transcripts
(Figure 4E), a marker of synaptic deﬁcits and motor dys-
function in adult axJ animals (Chen et al., 2009, 2011).
Finally, whereas overexpression of ubiquitin in the TgUb
mice had no eﬀect on rotarod performance, increased levels
of ubiquitin in the TgUb-H mice caused them to fall from
the rotating beam more quickly than controls (Figure 4F),
and display an abnormal gait while performing this task
(data not shown). Together, these data show that ubiqui-
tin has dose-dependent eﬀects on motor function and muscle
development.
Ubiquitin Overexpression Corrects
Presynaptic Structural Deficits at the TgCA
NMJ
We have previously reported that the NMJs of 4- to 6-
weeks-old USP14-deﬁcient axJ mice have poor motor end-
plate arborization, swollen presynaptic terminals, and ultra-
terminal sprouting, and that these deﬁcits are corrected in
axJTgUb mice (Chen et al., 2011). Because TgCA mice reca-
pitulate these axJ NMJ deﬁcits (Vaden et al., 2015), we inves-
tigated whether NMJ structure was improved in TgCA,TgUb
mice (Figure 5A). Whereas 56% of TgCA NMJs had presy-
naptic swellings, ubiquitin overexpression improved NMJ struc-
ture and only 11% of TgCA,TgUb terminals were swollen
(Figure 5B). Similarly, we observed ultra-terminal or ultra-
axonal sprouting in 50% of the terminals of the TgCA mice
compared to only 17% in the TgCA,TgUb mice (Figure 5C).
Terminal swelling and sprouting were seen only rarely in wild
type and TgUb mice (Figures 5B,C). We found a signiﬁ-
cant eﬀect of genotype on endplate area, with smaller, more
plaque-like endplates in the TgCA and TgCA,TgUb mice than
wild type and TgUb mice (Figure 5D), consistent with the
increase in AChR mRNA abundance observed in these mice
(Figure 3).
Ubiquitin Complementation Reduces pJNK
at the NMJs, but Not in the Spinal Cords, of
the TgCA Mice
We recently reported that pJNK is a prominent compo-
nent of the terminal swellings and sproutings in TgCA mice,
and that the extent of this pathology is reduced by treat-
ment with the JNK inhibitor SP600125 (Vaden et al., 2015).
Because ubiquitin complementation improved the structure
of the TgCA endplates (Figure 5), we investigated whether
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FIGURE 4 | Dose-dependent effects of ubiquitin on muscle
development and motor function. (A) Representative immunoblots of free
and conjugated ubiquitin in spinal cords from two lines of transgenic mice
over-expressing ubiquitin under the neuronal Thy1.2 promoter. β-tubulin was
used as a loading control. (B) Quantitation of the levels of ubiquitin
conjugates, normalized to wild type levels; [F (2,39) = 10.10, p < 0.001,
one-way ANOVA]. (C) Quantitation of the levels of free ubiquitin, normalized
to wild type levels; [F (2,38) = 24.01, p < 0.0001, one-way ANOVA].
(D) Comparison of gastrocnemius muscle mass from 4- to 5-weeks-old
female mice; [F (2,23) = 89.83, p < 0.0001, one-way ANOVA]. The same
effect was observed in male mice; [F (2,19) = 17.35, p < 0.0001, one-way
ANOVA]. (E) Comparison of AChR-γ transcript abundance, normalized to
wild type [F (2,12) = 185.5, p < 0.0001]. For (B–E) symbols represent
unpaired t-tests compared against wild type and corrected for multiple
comparisons with a Bonferroni adjustment where ∗∗p < 0.01, ∗∗∗p < 0.001.
(F) Latency to fall from beam during a rotarod assay (H = 12.22, 1 df,
p < 0.01, Kruskal–Wallis test), symbol represents Mann–Whitney test
compared against wild type and corrected for multiple comparisons with a
Bonferroni adjustment where ∗∗∗p < 0.001. For (D–F), n = at least five
animals per genotype. All data are shown as mean ± SEM.
this reduction in pathology was associated with a reduction
of pJNK at the NMJ. As previously reported, we observed
strong pJNK immunostaining in the presynaptic terminals of
TgCA mice (Figure 6A): 55.8% of terminals contained pJNK-
positive swellings (Figure 6B) and 43.5% of terminals contained
pJNK-positive ultra-terminal sprouts (Figure 6C). In contrast,
ubiquitin overexpression in the TgCA,TgUb mice reduced the
pathology, and only 8.3% of terminals contained pJNK-positive
swelling or sprouting (Figures 6B,C). pJNK-positive pathol-
ogy was negligible in wild type mice and absent in TgUb
mice. However, when we immunoblotted spinal cord lysates
from wild type, TgCA, TgCA,TgUb, and TgUb mice with a
pJNK-speciﬁc antibody, we found that the levels of pJNK in
TgCA,TgUb mice were elevated over the levels observed in
TgCA mice, and that spinal cord lysates of both genotypes
had signiﬁcantly more pJNK than spinal cord lysates from
wild type mice (Figures 7A,B). There was no change in
total JNK abundance in the TgCA or TgCA,TgUb mice com-
pared to controls, indicating that USP14 and ubiquitin regu-
late JNK activation and not JNK stability. We also observed
a signiﬁcant decrease in the abundance of pJNK, but not
total JNK, in TgUb spinal cord lysates compared to controls
(Figures 7A,B). A schematic summarizing the levels of pJNK
abundance observed in the spinal cords, distal motor neuron
axons, and NMJs of wild type, TgCA, and TgCA,TgUb mice is
shown in Figure 7C.
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FIGURE 5 | Ubiquitin complementation improves NMJ structure in TgCA
mice. (A) Whole-mount immunostaining of tibialis anterior (TA) muscles from
4- to 5-weeks-old wild type; TgCA, TgCA, TgUb, and TgUb mice expressing
YFP (green) under the neuronal Thy1.2 promoter. AChR clusters were visualized
with rhodamine-conjugated α-bungarotoxin (α-BTX, red). Arrowhead indicates
terminal swelling and arrows indicate ultra-terminal sprouting. Scale bar
represents 50 μM. (B) Percent of NMJs with presynaptic swellings or
(C) sproutings. (D) Quantitation of α-BTX-positive endplate area shown as
mean ± SEM. [F (3,564) = 104.60; p < 0.0001, one-way ANOVA]. Symbols in
(C) represent unpaired t-tests compared against wild type and corrected for
multiple comparisons with a Bonferroni adjustment, where ∗∗∗p < 0.001. For
(B–D), n = at least 130 NMJs from five animals.
Discussion
Three main conclusions can be drawn from these studies. First,
overexpression of ubiquitin increased the abundance of ubiq-
uitin conjugates in the spinal cord (Figure 4), demonstrat-
ing that free ubiquitin is a limiting factor in some ubiquitin-
dependent processes in the nervous system. Second, USP14’s
ubiquitin hydrolase activity plays a signiﬁcant role in regu-
lating the distribution of free and conjugated ubiquitin pools
in neurons (Figure 1). The increased abundance of ubiqui-
tin conjugates, and not depletion of the free ubiquitin pool,
directly correlated with impaired motor function when USP14’s
ubiquitin hydrolase activity was inhibited (Figures 2 and 3).
Third, both ubiquitin levels and the catalytic activity of USP14
impact the abundance of pJNK at the NMJ and in the
spinal cord (Figures 6 and 7) and, in turn, the levels of
pJNK at the NMJ impact the structure of the presynaptic
terminal.
Neuronal overexpression of ubiquitin led to increased ubiq-
uitin conjugates in a dose-dependent manner in two transgenic
founder lines, TgUb and TgUb-H, with low and high levels of
ubiquitin overexpression, respectively (Figure 4A). These ubiq-
uitin conjugates had dose-dependent eﬀects on motor func-
tion and muscle development in wild type mice (Figure 4).
Mild ubiquitin overexpression led to increased muscle devel-
opment and reduced expression of the fetal γ subunit of the
muscle AChR, which is correlated with enhanced NMJ synap-
tic transmission (Chen et al., 2009, 2011; Vaden et al., 2015),
in TgUb mice compared to controls (Figures 4B–D). In con-
trast, more dramatic ubiquitin overexpression reduced mus-
cle development, increased AChR-γ abundance, and hindered
motor performance in the TgUb-H mice compared to controls
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FIGURE 6 | Ubiquitin complementation reduces pJNK levels at the
NMJs of TgCA mice. (A) Whole-mount immunostaining of TA muscles
from 4- to 5-weeks-old wild type; TgCA, TgCA, TgUb, and TgUb mice
expressing YFP (green) under the neuronal Thy1.2 promoter using an
antibody against pJNK (light blue). Endplates were visualized with
rhodamine-conjugated α-bungarotoxin (α-BTX, red). Arrowheads indicate
pJNK-positive terminal swelling and arrows indicate pJNK-positive
ultra-terminal sprouting. Scale bar represents 50 μM. Quantitation of
(B) presynaptic swellings or (C) ultra-terminal sproutings. The patterned
portion of each bar represents pJNK-positive swellings and the height of
the bar represents the total percent of swollen NMJs. n = at least 60
NMJs from three animals per genotype.
(Figures 4B–D). Moreover, we have previously reported that
the TgUb-H mice develop adult-onset motor endplate disease
(Hallengren et al., 2013). Together, these data highlight the
importance of maintaining ubiquitin levels within a relatively
narrow window.
Ubiquitin-speciﬁc protease 14 is an important regulator of
ubiquitin homeostasis. We found that increasing the level of
wild type USP14 in the nervous system resulted in an increase
in the free ubiquitin pool and decreased levels of ubiqui-
tin conjugates as compared to controls. Because both the axJ
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FIGURE 7 | Ubiquitin overexpression does not reduce pJNK
abundance in TgCA spinal cords. (A) Representative immunoblots of
pJNK and total Jun N-terminal kinase (JNK) from spinal cords of
4 weeks-old wild type, TgCA, TgCA,TgUb, and TgUb mice. β-tubulin was
used as a loading control. (B) Quantitation of pJNK levels in 4-weeks-old
mice normalized to wt and total JNK abundance [F (3,36) = 9.532;
p < 0.0001, one-way ANOVA]. Symbols represent unpaired t-tests corrected
for multiple comparisons with a Bonferroni adjustment, where ∗p < 0.05,
∗∗p < 0.01. (C) Schematic representation of the levels of pJNK abundance
observed in the spinal cords, distal axons of motor neurons, and NMJs of
4- to 5-weeks-old mice of the genotypes indicated, where darker green
indicates greater pJNK abundance.
mice and TgCA mice exhibit severe motor endplate disease,
we were surprised to ﬁnd diﬀerences in ubiquitin homeosta-
sis between these two mouse lines. Loss of USP14 in the axJ
mice signiﬁcantly reduced the abundance of both free and
conjugated ubiquitin. In contrast, expression of catalytically
inactive USP14CA in the TgCA mice led to a 40% increase
in ubiquitin conjugates and a 25% reduction of free ubiq-
uitin. Further studies will be required to determine if these
eﬀects of USP14 on ubiquitin pools are due to changes in
ubiquitin-dependent degradation by the proteasome. These dif-
ferences in ubiquitin homeostasis in the spinal cords of the
axJ and TgCA mice, along with the dose-dependent impact of
increased ubiquitin conjugates on motor function and muscle
development, may provide a framework for understanding
the opposite eﬀects of ubiquitin overexpression in the axJ
and TgCA mice. One possibility for these diﬀerences is that
USP14CA may have an increased aﬃnity for its substrates com-
pared to USP14. Binding of USP14CA may slow their even-
tual deubiquitination by another DUB and result in prolonged
ubiquitin-dependent signaling. Alternatively, increased aﬃnity of
USP14CA to ubiquitin conjugates may block their proteasomal
degradation and lead to protein aggregation that could aﬀect
synaptic function.
In the axJ , TgUb mice, the levels of ubiquitin conjugates and
free ubiquitin are slightly elevated over what is normally observed
in wild type mice (Chen et al., 2011). We have now shown that
a modest increase in ubiquitin conjugates and free ubiquitin in
the TgUb mice correlated with increased muscle development
and motor function, even when wild type USP14 was present
(Figure 4). In contrast, the levels of ubiquitin conjugates in the
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spinal cords of the TgCA, TgUb mice were nearly twofold what
is observed in wild type mice (Figures 2A,B), and reduced mus-
cle development and mobility were observed in the TgCA,TgUb
mice compared to both wild type and TgCA mice. Our stud-
ies of the TgUb-H mice indicated that a twofold increase in
ubiquitin conjugates resulted in deﬁcits in motor function and
muscle development even when USP14’s catalytic activity was
intact (Figure 4). Together, these data open the possibility that
the restoration of motor neuron function in axJTgUb mice is
indirect and can be attributed to increased ubiquitin conjugates,
while suggesting that ubiquitin overexpression aggravates the
accumulation of ubiquitin conjugates caused by loss of USP14’s
DUB activity in TgCAmice to exaggerate the existing phenotype
(Figures 2 and 3). Since both increases and decreases in ubiquitin
pools are associated with deleterious eﬀects in cells and animals
models (Parag et al., 1987; Ferguson et al., 1990; Osaka et al., 2003;
Anderson et al., 2005; Hirsch et al., 2006) the ubiquitin depletion
observed in the absence of functional USP14 may contribute to
other neurological deﬁcits observed in the TgCA and axJ mice.
However, when considered together with our previous work
demonstrating a role for pJNK in the NMJ pathology observed in
the TgCAmice (Vaden et al., 2015), this study suggests that ubiq-
uitin complementation corrects these structural deﬁcits directly,
by reducing pJNK-positive pathology (Figures 5 and 6). While
we have not examined pJNK abundance at the NMJs of axJ
mice, the increased JNK activation in axJ spinal cords suggests
that the mechanism underlying NMJ pathology caused by loss of
USP14 is the same as that caused by loss of USP14’s DUB activity
(Vaden et al., 2015). Given the reduction of pJNK at TgCA,TgUb
NMJs compared to TgCA NMJs (Figure 6), we were surprised
by the dramatic increase in pJNK levels in the spinal cords of
the TgCA,TgUbmice (Figures 7A,B). However, we have recently
reported that loss of USP14’s DUB activity leads to enhanced
K63-linked ubiquitination of MLK3 (Vaden et al., 2015), which
drives it to dimerize, autophosphorylate, and activate its imme-
diate downstream targets, MKK4/7, which, in turn, activate JNK
(Humphrey et al., 2013). It is therefore possible that the increased
JNK activation that we observed in TgCA,TgUb spinal cords
compared to TgCA spinal cords (Figures 7A,B) results from
increased activation of MLK3.
The means by which ubiquitin complementation reduced
pJNK-positive pathology at the NMJ remains unclear. One possi-
bility is that the increased ubiquitin in TgCA,TgUb mice stim-
ulates the degradation of pJNK or its upstream kinases at the
NMJ or, alternatively, that ubiquitin contributes to the activation
of phosphatases that act on pJNK. Both of these explanations
are consistent with the reduction of pJNK abundance in TgUb
spinal cords compared to wild type, but not with the increase in
pJNK levels over both wild type and TgCA levels in the spinal
cords of the TgCA,TgUb mice (Figures 7A,B). In contrast, the
well-documented retrograde axonal transport of activated JNK
(Cavalli et al., 2005; Lindwall and Kanje, 2005; Shin et al., 2012;
Drerup and Nechiporuk, 2013) and the pJNK-positive swellings
at TgCA NMJs (Figure 6) are all consistent with a deﬁcit in
the retrograde transport of pJNK out of axon terminals in the
TgCA mice. The lack of pJNK-positive pathology in the nerve
terminals (Figure 6) of the TgCA,TgUbmice, combined with the
robust elevation of pJNK abundance in TgCA,TgUb spinal cords
(Figures 7A,B), the site of motor neuron cell bodies, suggest that
ubiquitin may stimulate the retrograde axonal transport of pJNK
(Figure 7C). Although a role for ubiquitin in retrograde axonal
transport has not been demonstrated directly, it was recently
reported that altered ubiquitin homeostasis contributes to the
deﬁcits in TrkB retrograde transport caused by the exposure of
cultured neurons to Aβ oligomers (Poon et al., 2013).
Finally, our ﬁndings also suggest that the functional deﬁcits
observed in the TgCA and axJ mice do not arise because
of altered NMJ structure. This is consistent with our previ-
ous report that acute inhibition of USP14 at the NMJs of
wild type mice causes deﬁcits in synaptic transmission that
are similar to what is observed in the TgCA and axJ mice,
while intramuscular injections of the same inhibitor given
over the course of a week do not cause NMJ pathology
(Vaden et al., 2015). Together, these ﬁndings may indicate
that USP14 regulates synapse structure and function through
distinct pathways. The same is true of the ubiquitin ligase
highwire, which regulates the structure and function of the
Drosophila NMJ through separate pathways (Collins et al.,
2006).
Acknowledgments
This work was supported by grants to UAB from the Howard
Hughes Medical Institute through the Med into Grad Initiative
(JV), the Civitan Research Center, the Evelyn F. McKnight Brain
Institute, and the National Institutes of Health (R01 NS047533
and R21 NS074456 to SW).
References
Anderson, C., Crimmins, S., Wilson, J. A., Korbel, G. A., Ploegh, H. L., and Wilson,
S. M. (2005). Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice.
J. Neurochem. 95, 724–731. doi: 10.1111/j.1471-4159.2005.03409.x
Baker, R. T., and Board, P. G. (1987). The human ubiquitin gene family: struc-
ture of a gene and pseudogenes from the Ub B subfamily. Nucleic Acids Res. 15,
443–463. doi: 10.1093/nar/15.2.443
Baker, R. T., and Board, P. G. (1991). The human ubiquitin-52 amino acid
fusion protein gene shares several structural features with mammalian ribo-
somal protein genes. Nucleic Acids Res. 19, 1035–1040. doi: 10.1093/nar/
19.5.1035
Cavalli, V., Kujala, P., Klumperman, J., and Goldstein, L. S.
(2005). Sunday Driver links axonal transport to damage sig-
naling. J. Cell Biol. 168, 775–787. doi: 10.1083/jcb.2004
10136
Chen, P. C., Bhattacharyya, B. J., Hanna, J., Minkel, H., Wilson, J. A., Finley, D.,
et al. (2011). Ubiquitin homeostasis is critical for synaptic development
and function. J. Neurosci. 31, 17505–17513. doi: 10.1523/JNEUROSCI.2922-
11.2011
Chen, P. C., Qin, L. N., Li, X. M., Walters, B. J., Wilson, J. A., Mei, L., et al. (2009).
The proteasome-associated deubiquitinating enzyme Usp14 is essential for the
maintenance of synaptic ubiquitin levels and the development of neuromuscu-
lar junctions. J. Neurosci. 29, 10909–10919. doi: 10.1523/jneurosci.2635-09.2009
Frontiers in Molecular Neuroscience | www.frontiersin.org 11 April 2015 | Volume 8 | Article 11
Vaden et al. USP14 and ubiquitin regulate the NMJ
Collins, C. A., Wairkar, Y. P., Johnson, S. L., and Diantonio, A. (2006). Highwire
restrains synaptic growth by attenuating a MAP kinase signal. Neuron 51,
57–69. doi: 10.1016/j.neuron.2006.05.026
Crimmins, S., Jin, Y., Wheeler, C., Huﬀman, A. K., Chapman, C., Dobrunz,
L. E., et al. (2006). Transgenic rescue of ataxia mice with neuronal-speciﬁc
expression of ubiquitin-speciﬁc protease 14. J. Neurosci. 26, 11423–11431. doi:
10.1523/JNEUROSCI.3600-06.2006
Drerup, C. M., and Nechiporuk, A. V. (2013). JNK-interacting protein 3 mediates
the retrograde transport of activated c-Jun N-terminal kinase and lysosomes.
PLoS Genet. 9:e1003303. doi: 10.1371/journal.pgen.1003303
Etter, P. D., Narayanan, R., Navratilova, Z., Patel, C., Bohmann, D., Jasper, H.,
et al. (2005). Synaptic and genomic responses to JNK and AP-1 signaling in
Drosophila neurons. BMC Neurosci. 6:39. doi: 10.1186/1471-2202-6-39
Ferguson, D. L., Guikema, J. A., and Paulsen, G. M. (1990). Ubiquitin pool modu-
lation and protein degradation in wheat roots during high temperature stress.
Plant Physiol. 92, 740–746. doi: 10.1104/pp.92.3.740
Finley, D., Bartel, B., and Varshavsky, A. (1989). The tails of ubiquitin precur-
sors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome
biogenesis.Nature 338, 394–401. doi: 10.1038/338394a0
Hallengren, J., Chen, P. C., and Wilson, S. M. (2013). Neuronal ubiquitin home-
ostasis. Cell Biochem. Biophys. 67, 67–73. doi: 10.1007/s12013-013-9634-4
Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev.
Biochem. 67, 425–479. doi: 10.1146/annurev.biochem.67.1.425
Hirsch, C., Gauss, R., and Sommer, T. (2006). Copingwith stress: cellular relaxation
techniques. Trends Cell Biol. 16, 657–663. doi: 10.1016/j.tcb.2006.10.006
Humphrey, R. K., Yu, S. M., Bellary, A., Gonuguntla, S., Yebra, M., and Jhala, U. S.
(2013). Lysine 63-linked ubiquitinationmodulatesmixed lineage kinase-3 inter-
action with JIP1 scaﬀold protein in cytokine-induced pancreatic beta cell death.
J. Biol. Chem. 288, 2428–2440. doi: 10.1074/jbc.M112.425884
Jara, J. H., Frank, D. D., and Ozdinler, P. H. (2013). Could dysregulation of UPS be
a common underlying mechanism for cancer and neurodegeneration? Lessons
from UCHL1. Cell Biochem. Biophys. 67, 45–53. doi: 10.1007/s12013-013-
9631-7
Lindwall, C., and Kanje, M. (2005). Retrograde axonal transport of JNK sig-
naling molecules inﬂuence injury induced nuclear changes in p-c-Jun and
ATF3 in adult rat sensory neurons. Mol. Cell. Neurosci. 29, 269–282. doi:
10.1016/j.mcn.2005.03.002
Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., et al.
(1988). Ubiquitin is a common factor in intermediate ﬁlament inclusion bodies
of diverse type inman, including those of Parkinson’s disease, Pick’s disease, and
Alzheimer’s disease, as well as Rosenthal ﬁbres in cerebellar astrocytomas, cyto-
plasmic bodies inmuscle, andmallory bodies in alcoholic liver disease. J. Pathol.
155, 9–15. doi: 10.1002/path.1711550105
Lund, P. K., Moats-Staats, B. M., Simmons, J. G., Hoyt, E., D’ercole, A. J.,Martin, F.,
et al. (1985). Nucleotide sequence analysis of a cDNA encoding human ubiq-
uitin reveals that ubiquitin is synthesized as a precursor. J. Biol. Chem. 260,
7609–7613. doi: 10.1002/path.1711550105
Osaka, H., Wang, Y. L., Takada, K., Takizawa, S., Setsuie, R., Li, H., et al. (2003).
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizesmonoubiquitin
in neuron. Hum. Mol. Genet. 12, 1945–1958. doi: 10.1093/hmg/ddg211
Parag, H. A., Raboy, B., and Kulka, R. G. (1987). Eﬀect of heat shock on protein
degradation in mammalian cells: involvement of the ubiquitin system. EMBO J.
6, 55–61.
Perry, G., Friedman, R., Shaw, G., and Chau, V. (1987). Ubiquitin is detected in
neuroﬁbrillary tangles and senile plaque neurites of Alzheimer disease brains.
Proc. Natl. Acad. Sci. U.S.A. 84, 3033–3036. doi: 10.1073/pnas.84.9.3033
Poon, W. W., Carlos, A. J., Aguilar, B. L., Berchtold, N. C., Kawano, C. K.,
Zograbyan, V., et al. (2013). beta-Amyloid (Abeta) oligomers impair brain-
derived neurotrophic factor retrograde traﬃcking by down-regulating ubiq-
uitin C-terminal hydrolase, UCH-L1. J. Biol. Chem. 288, 16937–16948. doi:
10.1074/jbc.M113.463711
Redman, K. L., and Rechsteiner, M. (1989). Identiﬁcation of the long ubiq-
uitin extension as ribosomal protein S27a. Nature 338, 438–440. doi:
10.1038/338438a0
Ryu, K. Y., Garza, J. C., Lu, X. Y., Barsh, G. S., and Kopito, R. R. (2008).
Hypothalamic neurodegeneration and adult-onset obesity in mice lacking the
Ubb polyubiquitin gene. Proc. Natl. Acad. Sci. U.S.A. 105, 4016–4021. doi:
10.1073/pnas.0800096105
Schmukle, A. C., and Walczak, H. (2012). No one can whistle a symphony alone
- how diﬀerent ubiquitin linkages cooperate to orchestrate NF-kappaB activity.
J. Cell Sci. 125, 549–559. doi: 10.1242/jcs.091793
Shin, J. E., Cho, Y., Beirowski, B., Milbrandt, J., Cavalli, V., and Diantonio, A.
(2012). Dual leucine zipper kinase is required for retrograde injury
signaling and axonal regeneration. Neuron 74, 1015–1022. doi:
10.1016/j.neuron.2012.04.028
Tanno, H., and Komada, M. (2013). The ubiquitin code and its decodingmachinery
in the endocytic pathway. J. Biochem. 153, 497–504. doi: 10.1093/jb/mvt028
Vaden, J. H., Bhattacharyya, B. J., Chen, P. C., Watson, J. A., Marshall, A. G.,
Phillips, S. E., et al. (2015). Ubiquitin-speciﬁc protease 14 regulates c-Jun N-
terminal kinase signaling at the neuromuscular junction. Mol. Neurodegener.
10:3. doi: 10.1186/1750-1326-10-3
Walters, B. J., Hallengren, J. J., Theile, C. S., Ploegh, H. L., Wilson, S. M., and
Dobrunz, L. E. (2014). A catalytic independent function of the deubiquitinat-
ing enzyme USP14 regulates hippocampal synaptic short-term plasticity and
vesicle number. J. Physiol. 592, 571–586. doi: 10.1113/jphysiol.2013.266015
Wiborg, O., Pedersen, M. S., Wind, A., Berglund, L. E., Marcker, K. A., and
Vuust, J. (1985). The human ubiquitin multigene family: some genes con-
tain multiple directly repeated ubiquitin coding sequences. EMBO J. 4,
755–759.
Yang, W. L., Wu, C. Y., Wu, J., and Lin, H. K. (2010). Regulation of Akt signaling
activation by ubiquitination. Cell Cycle 9, 487–497. doi: 10.4161/cc.9.3.10508
Zhou, A. Y., Shen, R. R., Kim, E., Lock, Y. J., Xu, M., Chen, Z. J., et al. (2013).
IKKepsilon-mediated tumorigenesis requires K63-linked polyubiquitination by
a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex. Cell Rep. 3, 724–733. doi:
10.1016/j.celrep.2013.01.031
Conflict of Interest Statement: Scott Wilson is a paid consultant for Progenera Inc.
The collection, analysis, and interpretation of the data presented in this manuscript
were not inﬂuenced by my relationship with Progenra Inc.
Copyright © 2015 Vaden, Watson, Howard, Chen, Wilson and Wilson. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Molecular Neuroscience | www.frontiersin.org 12 April 2015 | Volume 8 | Article 11
